Inogen Inc (INGN)
6.58
-0.47
(-6.67%)
USD |
NASDAQ |
Apr 25, 12:30
Inogen Price to Book Value: 0.7495 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 24, 2024 | 0.803 |
April 23, 2024 | 0.7859 |
April 22, 2024 | 0.7631 |
April 19, 2024 | 0.7688 |
April 18, 2024 | 0.8075 |
April 17, 2024 | 0.7916 |
April 16, 2024 | 0.7893 |
April 15, 2024 | 0.8155 |
April 12, 2024 | 0.8383 |
April 11, 2024 | 0.8291 |
April 10, 2024 | 0.8428 |
April 09, 2024 | 0.8793 |
April 08, 2024 | 0.7323 |
April 05, 2024 | 0.7175 |
April 04, 2024 | 0.7574 |
April 03, 2024 | 0.7904 |
April 02, 2024 | 0.8075 |
April 01, 2024 | 0.8588 |
March 28, 2024 | 0.9191 |
March 27, 2024 | 0.9072 |
March 26, 2024 | 0.8815 |
March 25, 2024 | 0.8565 |
March 22, 2024 | 0.8052 |
March 21, 2024 | 0.8109 |
March 20, 2024 | 0.7847 |
Date | Value |
---|---|
March 19, 2024 | 0.7802 |
March 18, 2024 | 0.779 |
March 15, 2024 | 0.7859 |
March 14, 2024 | 0.7688 |
March 13, 2024 | 0.8132 |
March 12, 2024 | 0.795 |
March 11, 2024 | 0.8189 |
March 08, 2024 | 0.8645 |
March 07, 2024 | 0.8588 |
March 06, 2024 | 0.8007 |
March 05, 2024 | 0.7688 |
March 04, 2024 | 0.7608 |
March 01, 2024 | 0.8001 |
February 29, 2024 | 0.7574 |
February 28, 2024 | 0.7164 |
February 27, 2024 | 1.064 |
February 26, 2024 | 1.057 |
February 23, 2024 | 1.047 |
February 22, 2024 | 1.050 |
February 21, 2024 | 1.052 |
February 20, 2024 | 1.063 |
February 16, 2024 | 1.124 |
February 15, 2024 | 1.137 |
February 14, 2024 | 0.9532 |
February 13, 2024 | 0.895 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4255
Minimum
Oct 27 2023
6.482
Maximum
May 06 2019
2.269
Average
1.962
Median
Price to Book Value Benchmarks
Oragenics Inc | 3.129 |
Palatin Technologies Inc | -- |
Oramed Pharmaceuticals Inc | 0.5565 |
vTv Therapeutics Inc | -- |
G1 Therapeutics Inc | 5.642 |
Price to Book Value Related Metrics
PS Ratio | 0.4831 |
PEG Ratio | -0.0728 |
Price | 6.58 |
Earnings Yield | -67.02% |
Market Cap | 153.49M |
PEGY Ratio | -0.0728 |